top of page
Speakers
Patrik Andersson, Ph.D.
AstraZeneca
Aravind Asokan, Ph.D.
Duke Department of Surgery
Peter Beal, Ph.D.
UC Davis Chemistry
Annabelle Biscans, Ph.D.
AstraZeneca
Alan Brown, MD
Advocate Aurora Health
Andreas Brunklaus
University of Glasgow
Olga Anczukow Camarda, Ph.D.
The Jackson Laboratory for Genomic Medicine
Thomas Carell Ph.D.
Ludwig-Maximilians-Universität (LMU) München
Don Cleveland, Ph.D.
UC San Diego
Rob Collin, Ph.D.
Radboud University Medical Center
Steven Ferguson, Ph.D.
University College Dublin
Camilla Foged Ph.D.
University of Copenhagen
Keith Gagnon, Ph.D.
Wake Forest University
Andy Geall, Ph.D.
Replicate Bioscience, Inc.
Aurélie Goyenvalle, Ph.D.
Laboratoire Biothérapies des Maladies Neuromusculaires
Reka Haraszti, Ph.D.
Universitätsklinikum Tübingen
Michelle Hastings, Ph.D.
University of Michigan Medical School
Samuel Hildebrand, Graduate Student
Umass Chan Medical School
Maja Janas, Ph.D., DABT
Alnylam Pharmaceuticals
Corrie Gallant-Behm
Atalanta Therapeutics
Krystal Johnson, Ph.D.
Alnylam Pharmaceuticals
Steven Jones, Ph.D.
SMA Patient Advocate
Adrian R. Krainer, Ph.D.
St. Giles Foundation Professor, Cold Spring Harbor Laboratory, CSHL Cancer Center
Edmund Lee, Ph.D.
Regulus Therapeutics
Marc Lemaitre, Ph.D.
Consultant, Stanford University
bottom of page